| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/2011 | US7910584 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof |
| 03/22/2011 | US7910583 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists |
| 03/22/2011 | US7910582 Cyclopropyl amines as modulators of the histamine H3 receptor |
| 03/22/2011 | US7910581 Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereof |
| 03/22/2011 | US7910580 Antitumor agents, anticancer agents; synergistic mixture; side effect reduction; inhibiting tumor growth in cancer patient by administering a combination therapy comprising 5-Fluorouracil (5-FU) and a methylol transfer agent capable of enhancing antineoplastic effect of 5-FU |
| 03/22/2011 | US7910579 Benzoxazole derivatives |
| 03/22/2011 | US7910578 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use |
| 03/22/2011 | US7910577 Injectable nanoparticulate olanzapine formulations |
| 03/22/2011 | US7910576 Pyrrole derivatives as P2Y12 antagonists |
| 03/22/2011 | US7910574 Treatments for the control of schistosomiasis |
| 03/22/2011 | US7910573 Methanol and ethanol solvates; breast cancer |
| 03/22/2011 | US7910571 3 beta -hydroxy-16 alpha -fluoro-17 beta -aminoandrost-5-ene; immunostimulant, antiinflammatory agent; neutropenia, infections, blood cell deficiencies; interleukin, tumor necrosis factor, macrophage inflammatory protein, transforming growth factor, cyclooxygenase, and lipoxygenase inhibitor |
| 03/22/2011 | US7910570 Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 03/22/2011 | US7910568 Derivatives of 4- or 5-aminosalicylic acid |
| 03/22/2011 | US7910567 Opticin nucleic acid administration reduces blood vessel formation |
| 03/22/2011 | US7910562 Method of delivering genes into antigen presenting cells of the skin |
| 03/22/2011 | US7910561 Inhibitors of Akt activity |
| 03/22/2011 | US7910560 Using natamycin; mixing with feed |
| 03/22/2011 | US7910559 Decladinosyl-macrolides with anti-inflammatory activity |
| 03/22/2011 | US7910558 therapy for gramnegative bacteria; antibiotics |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910545 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 03/22/2011 | US7910541 Enzyme treatment of foodstuffs for celiac sprue |
| 03/22/2011 | US7910307 Eubacterial tmRNA sequences and uses thereof |
| 03/22/2011 | US7910139 Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 03/22/2011 | US7910138 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin |
| 03/22/2011 | US7910137 Metal carnitine chelates |
| 03/22/2011 | US7910135 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 03/22/2011 | US7910134 Alloplastic injectable dermal filler and methods of use thereof |
| 03/22/2011 | US7910133 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 03/22/2011 | US7910132 Pharmaceutical composition for the treatment of acute disorders |
| 03/22/2011 | US7910130 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor |
| 03/22/2011 | US7910128 sustained release profile at lower pH and an accelerated dissolution profile at higher pH; improved bioavailability |
| 03/22/2011 | US7910126 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same |
| 03/22/2011 | US7910120 Adhesive block ethylenic copolymers, cosmetic compositions containing them and cosmetic use of these copolymers |
| 03/22/2011 | US7910117 Vaccine |
| 03/22/2011 | US7910114 Methods of treating infectious diseases |
| 03/22/2011 | US7910106 Combinations of SAP depleting agents and anti-SAP antibodies |
| 03/22/2011 | US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 03/22/2011 | US7910090 Non-irritating compositions |
| 03/22/2011 | US7910089 Sialogogue, oral composition and food product containing the same |
| 03/22/2011 | US7910087 Generating light |
| 03/22/2011 | US7908735 Method and installation means for installing an electrical machine |
| 03/22/2011 | CA2669827C Compositions comprising a mixture of bioflavonols |
| 03/22/2011 | CA2639349C Derivatives of 1,2,4,5-tetrahydro-3h-benzazepines, their preparation and pharmaceutical compositions containing them |
| 03/22/2011 | CA2632091C Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production |
| 03/22/2011 | CA2622334C Thiophene derivatives for the treatment of diabetes |
| 03/22/2011 | CA2615856C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 03/22/2011 | CA2614979C Piretanide polymorph, process for its preparation and its use |
| 03/22/2011 | CA2614443C Pyrido [2,3-d] pyrimidine-2,4-diamine compounds as ptp1b inhibitors |
| 03/22/2011 | CA2569742C Opioids for the treatment of the restless leg syndrome |
| 03/22/2011 | CA2553381C Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 03/22/2011 | CA2536149C Stable polymorph of bifeprunox mesilate(7-(4-(1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-2(3h)-benzoxazolone monomethanesulfonate) |
| 03/22/2011 | CA2525970C Use of nilvadipine for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 03/22/2011 | CA2521398C A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
| 03/22/2011 | CA2500824C Tricyclic tetrahydroquinoline antibacterial agents |
| 03/22/2011 | CA2498091C Sulfonylamino-acetic acid derivatives |
| 03/22/2011 | CA2497440C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2487238C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/22/2011 | CA2484275C Warming and nonirritating lubricant compositions and method of comparing irritation |
| 03/22/2011 | CA2480880C Inhibitors of akt activity |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2478229C Pyridinoylpiperidines as 5-ht1f agonists |
| 03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
| 03/22/2011 | CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 03/22/2011 | CA2471543C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2464735C An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 03/22/2011 | CA2464067C Method for treating non-neuropathic pain |
| 03/22/2011 | CA2460036C Medical devices containing rapamycin analogs |
| 03/22/2011 | CA2454228C Radiolabeled neuropeptide y y5 receptor antagonists |
| 03/22/2011 | CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2433603C Kappa opioid receptor ligands |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/22/2011 | CA2417331C Transplant media comprising bnp-1 |
| 03/22/2011 | CA2416819C Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 03/22/2011 | CA2407592C Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 03/22/2011 | CA2406201C Improvements in or relating to formulations for use in inhaler devices |
| 03/22/2011 | CA2397294C Glyburide composition |
| 03/22/2011 | CA2396186C Agents for the treatment of skin disorders |
| 03/22/2011 | CA2382636C Fish feed with increased nucleotide content |
| 03/22/2011 | CA2379581C Echinacea supplement and method of manufacture |
| 03/22/2011 | CA2376797C Administration of non oral androgenic steroids to women |
| 03/22/2011 | CA2371765C Isoflavone metabolites |
| 03/22/2011 | CA2344690C Fructosamine oxidase: antagonists and inhibitors |
| 03/22/2011 | CA2335941C Treatment of hyperproliferative disorders |
| 03/22/2011 | CA2333965C Method of enhancing lysosomal .alpha.-galactosidase a |
| 03/22/2011 | CA2280949C Dextran derivatives, preparation method and applications as medicine with specific biological action |
| 03/22/2011 | CA2264483C Method for recombinant adeno-associated virus-directed gene therapy |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/22/2011 | CA2136958C Method for inhibition of viral morphogenesis |
| 03/17/2011 | WO2011032175A1 Combination formulations of tranilast and allopurinol and methods related thereto |
| 03/17/2011 | WO2011032169A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 03/17/2011 | WO2011032159A1 Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent |